Apply to join
Member Sign In
Member Sign Out
Cell & Gene Therapy
Apply to Join
Cancer & Disease Research
Sponsored by Beckman Coulter
New molecular cause identified for neurodegeneration in Alzheimer's disease
A collaborative research effort uncovered evidence for a new molecular basis for neurodegeneration seen in patients with Alzheimer's disease. Researchers from Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital published the study in
on October 8.
Repurposed drug shows potential to slow neurodegeneration in Parkinson's disease patients
Collaborative research from the University of Iowa and researchers in China and Spain, show evidence that a current drug used to treat prostate cancer may improve Parkinson's disease (PD) symptoms by slow neurodegeneration. The results from experimental models and clinical database analysis were published on September 16, in the Journal of Clinical Investigation.
New Applications of Synthetic Biology to Cancer Research Challenges: 2020 Virtual Jumpstart
Japan Analytical & Scientific Instruments Show (JASIS)
Chiba, Chiba Japan
2020 AACC Annual Scientific Meeting & Clinical Lab Expo
Society for Laboratory Automation and Screening (SLAS) 2021
January 23-27, 2021
San Diego, California United States
Festival of Genomics & Biodata
January 28-29, 2021
London, Greater London United Kingdom
More Conferences »»
Avrobio gets orphan drug nod for Fabry disease gene therapy
Takeda expands COVID-19 vaccine supply with Moderna, Japan
Emulate to provide FDA with 'lung chips' to evaluate COVID-19 vaccines
Qualigen to advance COVID-19 DNA aptamer drug candidate
Merck acquires Seagen for $1B
More articles »
Exclusive content for Science Advisory Board members on trends and outcomes that are influencing the future of scientific research.
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Earn points for contributing to research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Tweets by @ScienceBoard